Ionis Pharmaceuticals IONS Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's total costs & expenses?
- Ionis Pharmaceuticals (IONS) reported total costs & expenses of $363.52M in Q1 2026.
- How has Ionis Pharmaceuticals's total costs & expenses changed year-over-year?
- Ionis Pharmaceuticals's total costs & expenses increased by 30.5% year-over-year, from $278.47M to $363.52M.
- What is the long-term trend for Ionis Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's total costs & expenses has grown at a 12.1% compound annual growth rate (CAGR), from $840.64M to $1.33B.
- What does total costs & expenses mean?
- The sum of all costs and expenses incurred by the company.
- How do you interpret total costs & expenses?
- A rapid increase in total expenses without a corresponding increase in revenue suggests a potential strain on cash flow and profitability.
- How does total costs & expenses compare across companies?
- Standard metric used to assess the overall cost structure relative to peers in the same industry.